Antibacterial properties of phage Abp1 endolysin (PlyAB1)

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Huang, Guangtao ^a   Shen, Xiaodong ^a   Gong, Yali ^a   Dong, Zhiwei ^a   Zhao, Xia ^a   Shen, Wei ^a   Wang, Jing ^a   Hu, Fuquan ^a   Peng, Yizhi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Endolysins; Multilocus sequence typing; Pandrug resistant Acinetobacter baumannii

Indexed keywords

ANTIINFECTIVE AGENT; PLYAB1 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; ENDOLYSIN; ENDOLYSIN, ACINETOBACTER BAUMANNII PHAGE; PROTEINASE; VIRUS PROTEIN;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG POTENCY; DRUG PURIFICATION; DRUG SCREENING; ESCHERICHIA COLI; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GROWTH INHIBITION; MOLECULAR CLONING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLYAB1 GENE; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENZYMOLOGY; VIROLOGY;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; BACTERIOPHAGES; DRUG RESISTANCE, BACTERIAL; ENDOPEPTIDASES; RECOMBINANT PROTEINS; VIRAL PROTEINS;

EID: 84923864536     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0681-2     Document Type: Article

References (26)

1. Peleg AY, Seifert H, Paterson DL: Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
2. Dijkshoorn L, Nemec A, Seifert H: An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5:939-951.
3. Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA: Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 2008, 190:8053-8064.
4. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, Richet H, Robert C, Mangenot S, Abergel C: Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet 2006, 2:e7.
5. Tan TY, Lim TP, Lee WH, Sasikala S, Hsu LY, Kwa AL: In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods. Antimicrob Agents Ch 2011, 55:436-438.
6. Loessner MJ: Bacteriophage endolysins-current state of research and applications. Curr Opin Microbiol 2005, 8:480-487.
7. Schmelcher M, Donovan DM, Loessner MJ: Bacteriophage endolysins as novel antimicrobials. Future Microbiol 2012, 7:1147-1171.
8. Jun SY, Jung GM, Yoon SJ, Choi YJ, Koh WS, Moon KS, Kang SH: Preclinical Safety Evaluation of Intravenously Administered SAL200 Containing the Recombinant Phage Endolysin SAL-1 as a Pharmaceutical Ingredient. Antimicrob Agents Chemother 2014, 58:2084-2088.
9. Doehn JM, Fischer K, Reppe K, Gutbier B, Tschernig T, Hocke AC, Fischetti VA, Loffler J, Suttorp N, Hippenstiel S, Witzenrath M: Delivery of the endolysin Cpl-1 by inhalation rescues mice with fatal pneumococcal pneumonia. J Antimicrob Chemother 2013, 68:2111-2117.
10. Huang G, Le S, Peng Y, Zhao Y, Yin S, Zhang L, Yao X, Tan Y, Li M, Hu F: Characterization and genome sequencing of phage Abp1, a new phiKMV-like virus infecting multidrug-resistant Acinetobacter baumannii. Curr Microbiol 2013, 66:535-543.
11. von Dippe P, Levy D: Characterization of the bile acid transport system in normal and transformed hepatocytes. Photoaffinity labeling of the taurocholate carrier protein. J Biol Chem 1983, 258:8896-8901.
12. Carvalho FG, Puppin-Rontani RM, Fucio SB, Negrini Tde C, Carlo HL, Garcia-Godoy F: Analysis by confocal laser scanning microscopy of the MDPB bactericidal effect on S. mutans biofilm CLSM analysis of MDPB bactericidal effect on biofilm. J Appl Oral Sci 2012, 20:568-575.
13. Ruan Z, Chen Y, Jiang Y, Zhou H, Zhou Z, Fu Y, Wang H, Wang Y, Yu Y: Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China. Int J Antimicrob Agents 2013, 42:322-328.
14. Yang H, Liang L, Lin S, Jia S: Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol 2010, 10:131.
15. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, Rodriguez-Valera F: Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005, 43:4382-4390.
16. Flach J, Pilet PE, Jolles P: What's new in chitinase research? Experientia 1992, 48:701-716.
17. Lai MJ, Lin NT, Hu A, Soo PC, Chen LK, Chen LH, Chang KC: Antibacterial activity of Acinetobacter baumannii phage varphiAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria. Appl Microbiol Biotechnol 2011, 90:529-539.
18. Lim CJ, Cheng AC, Kennon J, Spelman D, Hale D, Melican G, Sidjabat HE, Paterson DL, Kong DC, Peleg AY: Prevalence of multidrug-resistant organisms and risk factors for carriage in long-term care facilities: a nested case-control study. J Antimicrob Chemother 2014, 69:1972-1980.
19. Lai MJ, Soo PC, Lin NT, Hu A, Chen YJ, Chen LK, Chang KC: Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978. Int J Antimicrob Ag 2013, 42:141-148.
20. Shen GH, Wang JL, Wen FS, Chang KM, Kuo CF, Lin CH, Luo HR, Hung CH: Isolation and characterization of phikm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii. PLoS One 2012, 7:e46537.
21. Diez-Martinez R, de Paz H, Bustamante N, Garcia E, Menendez M, Garcia P: Improving the lethal effect of cpl-7, a pneumococcal phage lysozyme with broad bactericidal activity, by inverting the net charge of its cell wall-binding module. Antimicrob Agents Ch 2013, 57:5355-5365.
22. Chen HL, Su PY, Chang YS, Wu SY, Liao YD, Yu HM, Lauderdale TL, Chang K, Shih C: Identification of a novel antimicrobial peptide from human hepatitis B virus core protein arginine-rich domain (ARD). PLoS Pathog 2013, 9:e1003425.
23. Briers Y, Walmagh M, Van Puyenbroeck V, Cornelissen A, Cenens W, Aertsen A, Oliveira H, Azeredo J, Verween G, Pirnay JP: Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens. MBio 2014, 5:e01379-14.
24. Hamouda A, Evans BA, Towner KJ, Amyes SG: Characterization of epidemiologically unrelated Acinetobacter baumannii isolates from four continents by use of multilocus sequence typing, pulsed-field gel electrophoresis, and sequence-based typing of bla(OXA-51-like) genes. J Clin Microbiol 2010, 48:2476-2483.
25. Regulski K, Courtin P, Kulakauskas S, Chapot-Chartier MP: A novel type of peptidoglycan-binding domain highly specific for amidated D-Asp cross-bridge, identified in Lactobacillus casei bacteriophage endolysins. J Biol Chem 2013, 288:20416-20426.
26. Ganguly J, Low LY, Kamal N, Saile E, Forsberg LS, Gutierrez-Sanchez G, Hoffmaster AR, Liddington R, Quinn CP, Carlson RW, Kannenberg EL: The secondary cell wall polysaccharide of Bacillus anthracis provides the specific binding ligand for the C-terminal cell wall-binding domain of two phage endolysins, PlyL and PlyG. Glycobiology 2013, 23:820-832.